Le Lézard
Classified in: Health, Business
Subjects: ERN, CCA

PharmaCielo to Hold Conference Call to Review Third Quarter 2019 Financial Results


TORONTO, Nov. 25, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO, OTC: PHCEF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announces today that it will host a conference call on Monday, November 25th, 2019, at 5:00 p.m. ET to discuss its third quarter financial results and provide investors with key business highlights. The call will be chaired by David Attard, CEO; David Gordon, CCO and Scott Laitinen, CFO.

PharmaCielo (CNW Group/PharmaCielo Ltd.)

CONFERENCE CALL DETAILS

Date: November 25th, 2019 | Time: 5:00pm ET

Participant Dial-in: 416-764-8688 or 1-888-390-0546

Replay Dial-in: 416-764-8677 or 1-888-390-0541

(Available for 2 weeks)

Conference ID: 30043730

Playback #: 043730

Listen to webcast: event.on24.com 

About PharmaCielo

PharmaCielo Ltd. (TSXV:PCLO, OTC:PHCEF) is a global company, headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its nursery and propagation centre located in Rionegro, Colombia.

The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia's ideal location will play in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, is executing on a business plan focused on supplying the international marketplace.

For further information:
www.PharmaCielo.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE PharmaCielo Ltd.


These press releases may also interest you

at 07:01
Halper Sadeh LLP, a global investor rights law firm, is investigating: Noble Energy, Inc.  concerning potential violations of the...

at 05:00
At the SNEC 14th (2020) International Photovoltaic Power Generation and Smart Energy Exhibition & Conference, Yingli Solar Reaches Strategic Cooperation with a Number of Important Partners....

at 00:00
Gulf Business Machines (GBM), a leading end-to-end digital solutions provider, offering industry-leading digital infrastructure, digital business solutions, security and services, has been recently recognized as one of the best places to work for in...

8 aoû 2020
National Trench Safety, LLC (NTS), a Houston-based company specializing in the rental and sales of trench and traffic safety equipment, along with trench and traffic safety engineering, and OSHA-compliant training classes, announced today the...

8 aoû 2020
Reading International, Inc. ("Reading") announced today that it expects to release its financial results for its second quarter ended June 30, 2020 on Monday, August 10, 2020 before the opening of the U.S. stock markets. Reading plans to post its...

8 aoû 2020
General Dynamics announced today that the negotiating teams from Bath Iron Works and the International Association of Machinists and Aerospace Workers (IAM) Local S6 reached agreement last night on mutually acceptable terms to end the ongoing strike...



News published on 25 november 2019 at 14:28 and distributed by: